Published in Eur Respir J on April 12, 2006
KOrea COpd Subgroup Registry and Subtype Research (KOCOSS) | NCT02800499
Icing and Airflow Stimulation in Obstructive Lung Diseases | NCT03887364
Critical review: vegetables and fruit in the prevention of chronic diseases. Eur J Nutr (2012) 3.48
COPD prevalence in a random population survey: a matter of definition. Eur Respir J (2007) 2.97
Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med (2007) 2.80
Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J (2009) 2.52
Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol (2008) 2.18
Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit. Respir Res (2008) 1.98
The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One (2013) 1.94
COPD surveillance--United States, 1999-2011. Chest (2013) 1.92
Impaired sleep reduces quality of life in chronic obstructive pulmonary disease. Lung (2009) 1.88
Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis (2012) 1.87
Exacerbation rate, health status and mortality in COPD--a review of potential interventions. Int J Chron Obstruct Pulmon Dis (2009) 1.85
A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. Br J Pharmacol (2007) 1.71
Can early diagnosis and effective management combat the irresistible rise of COPD? Br J Gen Pract (2006) 1.66
The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. BMC Health Serv Res (2011) 1.62
Cigarette smoke suppresses Bik to cause epithelial cell hyperplasia and mucous cell metaplasia. Am J Respir Crit Care Med (2011) 1.57
Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One (2009) 1.56
Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD. Respir Res (2011) 1.52
Barriers to adherence to COPD guidelines among primary care providers. Respir Med (2011) 1.47
Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model. Am J Respir Cell Mol Biol (2008) 1.44
[The prevalence of COPD in Austria--the expected change over the next decade]. Wien Klin Wochenschr (2007) 1.43
COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population. BMC Public Health (2011) 1.39
Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012-2013. Int J Chron Obstruct Pulmon Dis (2014) 1.32
Prevalence of COPD and its association with socioeconomic status in China: findings from China Chronic Disease Risk Factor Surveillance 2007. BMC Public Health (2011) 1.24
Do symptoms predict COPD in smokers? Chest (2010) 1.22
Correlation between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome in a general population in Iran. J Res Med Sci (2011) 1.22
Subclinical atherosclerotic vascular disease in chronic obstructive pulmonary disease: Prospective hospital-based case control study. Lung India (2015) 1.21
Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction. Open Heart (2014) 1.20
Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study. BMC Fam Pract (2013) 1.18
Physical activity and quality of life in subjects with chronic disease: chronic obstructive pulmonary disease compared with rheumatoid arthritis and diabetes mellitus. Scand J Prim Health Care (2009) 1.17
Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2007) 1.14
Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India (2013) 1.13
Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Eur J Heart Fail (2009) 1.13
Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010. Respir Res (2013) 1.13
Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer. Int J Chron Obstruct Pulmon Dis (2011) 1.11
Patient-clinician communication: associations with important health outcomes among veterans with COPD. Chest (2010) 1.11
Prevalence of tracheal collapse in an emphysema cohort as measured with end-expiration CT. Acad Radiol (2009) 1.09
Implementation of a targeted screening program to detect airflow obstruction suggestive of chronic obstructive pulmonary disease within a presurgical screening clinic. Can Respir J (2015) 1.09
Improving medication adherence in chronic obstructive pulmonary disease: a systematic review. Respir Res (2013) 1.09
Updates on the COPD gene list. Int J Chron Obstruct Pulmon Dis (2012) 1.08
Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: a randomized crossover trial. PLoS One (2012) 1.08
Perioperative medical management of patients with COPD. Int J Chron Obstruct Pulmon Dis (2007) 1.06
Case finding for chronic obstructive pulmonary disease: a model for optimising a targeted approach. Thorax (2010) 1.06
Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health (2015) 1.06
Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study. BMC Infect Dis (2013) 1.05
Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2014) 1.05
Trends in COPD prevalence and exacerbation rates in Dutch primary care. Br J Gen Pract (2009) 1.04
Heart failure with preserved ejection fraction in the elderly: scope of the problem. Heart Fail Rev (2012) 1.04
Chronic obstructive pulmonary disease as a risk factor for lung cancer. World J Clin Oncol (2014) 1.02
Regional variations in the prevalence and misdiagnosis of air flow obstruction in China: baseline results from a prospective cohort of the China Kadoorie Biobank (CKB). BMJ Open Respir Res (2014) 1.02
Treatment of respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis (2008) 1.02
Derivation of normative data for the COPD assessment test (CAT). Respir Res (2014) 1.02
Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims. Int J Chron Obstruct Pulmon Dis (2011) 1.02
Chronic obstructive pulmonary disease. Indian J Med Res (2013) 1.02
Mechanisms of atherothrombosis in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2008) 1.01
Novel autoantigens immunogenic in COPD patients. Respir Res (2009) 1.01
Disability and chronic disease among older adults in India: detecting vulnerable populations through the WHO SAGE Study. Am J Epidemiol (2013) 1.01
Autophagy: a core cellular process with emerging links to pulmonary disease. Am J Respir Crit Care Med (2011) 1.00
Health-related quality of life in outpatients with COPD in daily practice: the VICE Spanish Study. Int J Chron Obstruct Pulmon Dis (2008) 0.99
Phenotyping of chronic obstructive pulmonary disease using the modified Bhalla scoring system for high-resolution computed tomography. Can Respir J (2013) 0.98
Geographic differences in clinical characteristics and management of COPD: the EPOCA study. Int J Chron Obstruct Pulmon Dis (2008) 0.98
Prevalence of chronic obstructive pulmonary disease in rural women of Tamilnadu: implications for refining disease burden assessments attributable to household biomass combustion. Glob Health Action (2011) 0.98
What proportion of lung cancer in never-smokers can be attributed to known risk factors? Int J Cancer (2012) 0.98
Anti-inflammatory effect of a selective IkappaB kinase-beta inhibitor in rat lung in response to LPS and cigarette smoke. Pulm Pharmacol Ther (2010) 0.98
The AIMAR recommendations for early diagnosis of chronic obstructive respiratory disease based on the WHO/GARD model*. Multidiscip Respir Med (2014) 0.97
Chronic obstructive pulmonary disease and association with mild cognitive impairment: the Mayo Clinic Study of Aging. Mayo Clin Proc (2013) 0.97
Chronic obstructive pulmonary disease in primary care: an epidemiologic cohort study from the Canadian Primary Care Sentinel Surveillance Network. CMAJ Open (2015) 0.97
Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey. Asia Pac Fam Med (2015) 0.97
Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction. BMC Pulm Med (2007) 0.96
The IRYSS-COPD appropriateness study: objectives, methodology, and description of the prospective cohort. BMC Health Serv Res (2011) 0.96
Interaction between smoking and genetic factors in the development of chronic bronchitis. Am J Respir Crit Care Med (2007) 0.95
Factors associated with good self-rated health and quality of life in subjects with self-reported COPD. Int J Chron Obstruct Pulmon Dis (2011) 0.95
Incidence and prevalence of chronic obstructive pulmonary disease among aboriginal peoples in Alberta, Canada. PLoS One (2015) 0.94
Emphysema lung lobe volume reduction: effects on the ipsilateral and contralateral lobes. Eur Radiol (2012) 0.94
Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2014) 0.94
Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice. Carcinogenesis (2009) 0.94
Predictive score for mortality in patients with COPD exacerbations attending hospital emergency departments. BMC Med (2014) 0.94
Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD. Int J Chron Obstruct Pulmon Dis (2013) 0.93
Predictors of cardiovascular disease in asthma and chronic obstructive pulmonary disease. Multidiscip Respir Med (2013) 0.92
Diminished ICAM-1 expression and impaired pulmonary clearance of nontypeable Haemophilus influenzae in a mouse model of chronic obstructive pulmonary disease/emphysema. Infect Immun (2008) 0.92
Bronchial asthma and chronic obstructive pulmonary disease: research activity in Arab countries. Multidiscip Respir Med (2014) 0.92
Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat. Indian J Endocrinol Metab (2014) 0.92
Study of the burden on patients with chronic obstructive pulmonary disease. Int J Clin Pract (2009) 0.91
Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study. BMC Infect Dis (2008) 0.90
A bibliometric analysis of the 100 most influential papers on COPD. Int J Chron Obstruct Pulmon Dis (2015) 0.90
Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbidities. Biomed Res Int (2014) 0.89
Comparative efficacy of indacaterol in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2012) 0.89
Large-scale genome-wide association studies and meta-analyses of longitudinal change in adult lung function. PLoS One (2014) 0.89
Natural history of emphysema. Proc Am Thorac Soc (2008) 0.89
Metabonomic profiling of serum and urine by (1)H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals. PLoS One (2013) 0.89
DAMPs activating innate and adaptive immune responses in COPD. Mucosal Immunol (2013) 0.89
Annual costs of chronic obstructive pulmonary disease in Finland during 1996-2006 and a prediction model for 2007-2030. NPJ Prim Care Respir Med (2015) 0.89
Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma. BMC Pulm Med (2011) 0.88
TNF-α is associated with loss of lean body mass only in already cachectic COPD patients. Respir Res (2012) 0.88
Detection and follow-up of chronic obstructive pulmonary disease (COPD) and risk factors in the Southern Cone of Latin America: the pulmonary risk in South America (PRISA) study. BMC Pulm Med (2011) 0.88
Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century. Int J Environ Res Public Health (2009) 0.88
Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan. Int J Chron Obstruct Pulmon Dis (2014) 0.88
Derivation and validation of clinical phenotypes for COPD: a systematic review. Respir Res (2015) 0.87
Prevalence of different comorbidities in COPD patients by gender and GOLD stage. Multidiscip Respir Med (2015) 0.87
Prevalence and global initiative for chronic obstructive lung disease group distribution of chronic obstructive pulmonary disease detected by preoperative pulmonary function test. PLoS One (2015) 0.87
The many faces of tobacco use among women. Med Sci Monit (2014) 0.86
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA (1994) 10.46
The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med (1992) 8.53
Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax (2003) 4.81
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med (2000) 3.43
Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest (1999) 3.28
Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest (2000) 3.12
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J (2002) 3.06
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
A dynamic population model of disease progression in COPD. Eur Respir J (2005) 2.59
Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J (2009) 2.52
Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med (1999) 2.36
Specialty differences in the management of asthma. A cross-sectional assessment of allergists' patients and generalists' patients in a large HMO. Arch Intern Med (1997) 2.28
Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health (1995) 2.16
A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med (1994) 2.11
Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. Ann Intern Med (2001) 2.06
Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data. Am J Med (1996) 2.04
Asthma mortality in U.S. Hispanics of Mexican, Puerto Rican, and Cuban heritage, 1990-1995. Am J Respir Crit Care Med (2000) 1.99
Spirometry in the Lung Health Study. 1. Methods and quality control. Am Rev Respir Dis (1991) 1.99
Predicted values for closing volumes using a modified single breath nitrogen test. Am Rev Respir Dis (1973) 1.89
Present and future costs of COPD in Iceland and Norway: results from the BOLD study. Eur Respir J (2009) 1.89
Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax (2000) 1.88
Chronic Obstructive Pulmonary Disease Early Intervention Trial (Lung Health Study). Baseline characteristics of randomized participants. Chest (1993) 1.85
Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis (1993) 1.82
Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration. Chest (1994) 1.71
Preventing deaths from asthma. N Engl J Med (1994) 1.70
Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? Int J Tuberc Lung Dis (2009) 1.60
Quantitative analysis of the alveolar plateau in the diagnosis of early airway obstruction. Am Rev Respir Dis (1973) 1.56
Restricted spirometry in the Burden of Lung Disease Study. Int J Tuberc Lung Dis (2012) 1.55
Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med (1998) 1.53
Relative impact of smoking and reduced pulmonary function on peptic ulcer risk. A prospective study of Japanese men in Hawaii. Gastroenterology (1989) 1.52
Monitoring recruitment effectiveness and cost in a clinical trial. Control Clin Trials (1993) 1.49
Associations of smoking with hospital-based care and quality of life in patients with obstructive airway disease. Chest (1999) 1.42
COPD exacerbations: the importance of a standard definition. Respir Med (2004) 1.42
Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med (1994) 1.42
Recruiting hard-to-reach subjects: is it worth the effort? Control Clin Trials (1994) 1.41
20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. Am J Respir Crit Care Med (1998) 1.40
Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. Am J Respir Crit Care Med (1995) 1.40
Caesarean section delivery and the risk of allergic disorders in childhood. Clin Exp Allergy (2005) 1.36
A comparison of conventional spirometric tests and the test of closing volume in an emphysema screening center. Am Rev Respir Dis (1973) 1.30
Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax (2008) 1.29
Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis (1991) 1.29
The effect of smoking cessation and modification on lung function. Am Rev Respir Dis (1976) 1.26
Risk factors for asthma incidence. A review of recent prospective evidence. Panminerva Med (2004) 1.24
Occupational exposures and COPD: an ecological analysis of international data. Eur Respir J (2008) 1.23
Worldwide epidemiology of chronic obstructive pulmonary disease. Curr Opin Pulm Med (1999) 1.23
Further investigation into the recent increase in asthma death rates: a review of 41 asthma deaths in Oregon in 1982. Ann Allergy (1988) 1.22
Body mass index and asthma incidence among USA adults. Eur Respir J (2004) 1.22
Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA (1993) 1.21
Sociodemographic correlates of indoor allergen sensitivity among United States children. J Allergy Clin Immunol (2001) 1.21
Acute effects of volcanic ash from Mount Saint Helens on lung function in children. Am Rev Respir Dis (1983) 1.15
C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults. Eur J Clin Nutr (2003) 1.14
The effect of smoking cessation on pulmonary function: a 30-month follow-up of two smoking cessation clinics. Am Rev Respir Dis (1979) 1.13
Use of an automated prescription database to identify individuals with asthma. J Clin Epidemiol (1995) 1.11
Defining chronic obstructive pulmonary disease... and the elephant in the room. Eur Respir J (2007) 1.10
Preventive health measures in volcanic eruptions. Am J Public Health (1986) 1.08
[The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study]. Dtsch Med Wochenschr (2008) 1.08
Experience of Black participants in the Lung Health Study smoking cessation intervention program. Nicotine Tob Res (2001) 1.04
Early detection of airways obstruction by the closing volume technique. Chest (1973) 1.02
Increasing U.S. asthma mortality rates: who is really dying? J Asthma (2001) 1.01
Risk factors for ARDS in the United States: analysis of the 1993 National Mortality Followback Study. Chest (2001) 1.00
Ocular effects following the volcanic eruptions of Mount St Helens. Arch Ophthalmol (1983) 1.00
Respiratory symptoms, lung function, and mortality in a screening center cohort. Am J Epidemiol (1989) 0.99
The natural history of air-flow obstruction in PiZ emphysema. Report of an NHLBI workshop. Am Rev Respir Dis (1983) 0.98
Twenty year trends in hospital discharges for asthma among members of a health maintenance organization. J Clin Epidemiol (1992) 0.97
Cystic fibrosis deaths in the United States from 1979 through 1991. An analysis using multiple-cause mortality data. Arch Pediatr Adolesc Med (1996) 0.96
Longitudinal versus cross-sectional estimation of lung function decline--further insights. Stat Med (1988) 0.96
Smoking cessation in primary care clinics. J Gen Intern Med (1999) 0.96
Relationship of response to a bronchodilator and decline in forced expiratory volume in one second in population studies. Am Rev Respir Dis (1985) 0.94
Spirometric screening: Does it work? Thorax (2006) 0.94
Methodologic issues in the analysis of lung function data. J Chronic Dis (1987) 0.93
Relationship between lung function and blood pressure in Chinese men and women of Beijing and Guangzhou. PRC-USA Cardiovascular and Cardiopulmonary Epidemiology Research Group. Int J Epidemiol (1998) 0.93
Evaluation of physical health effects due to volcanic hazards: human studies. Am J Public Health (1986) 0.92
Reversing concepts on COPD irreversibility. Eur Respir J (2008) 0.92
Long-term follow-up of a cohort of children with alpha-1-antitrypsin deficiency. J Pediatr (1990) 0.92
National Asthma Education and Prevention Program working group report on the cost effectiveness of asthma care. Am J Respir Crit Care Med (1996) 0.89
Cigarette smoking and thyroid hormone levels in males. Int J Epidemiol (1997) 0.89
Quality control of spirometry testing in the registry for patients with severe alpha1-antitrypsin deficiency. alpha1-Antitrypsin Deficiency Registry Study Group. Chest (1997) 0.89
Outdoor and indoor air pollution and COPD-related diseases in high- and low-income countries. Int J Tuberc Lung Dis (2008) 0.89
Farming and the prevalence of non-reversible airways obstruction: results from a population-based study. Am J Ind Med (2007) 0.89
Cost of fractures commonly associated with osteoporosis in a managed-care population. J Med Econ (2010) 0.88
Are volcanoes hazardous to your health? What have we learned from Mount St Helens? West J Med (1982) 0.88
Lack of correlation of symptoms with specialist-assessed long-term asthma severity. Chest (1999) 0.88
Urinary excretion of desmosine (elastin cross-links) in subjects with PiZZ alpha-1-antitrypsin deficiency, a phenotype associated with hereditary predisposition to pulmonary emphysema. Am Rev Respir Dis (1985) 0.88
What are the risks of third-generation oral contraceptives? Are third-generation oral contraceptives safe? Hum Reprod (1996) 0.87
Health effects of volcanoes: an approach to evaluating the health effects of an environmental hazard. Am J Public Health (1986) 0.86
Pulmonary fibrosis and lung cancer in the United States: analysis of the multiple cause of death mortality data, 1979 through 1991. South Med J (1996) 0.86
Dietary vitamin C intake is inversely related to cough and wheeze in young smokers. Respir Med (2003) 0.86
Relationship between serum IgE and cross-sectional and longitudinal FEV1 in two cohort studies. Chest (1986) 0.86
Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Respir Care (2000) 0.85
New tests to assess lung function. The single-breath nitrogen test. N Engl J Med (1975) 0.85
Health outcomes assessment and economic evaluation in COPD: challenges and opportunities. Eur Respir J Suppl (2003) 0.84
Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med (2000) 0.84
Insight into patient dissatisfaction with asthma treatment. Arch Intern Med (2001) 0.84
Correlates of FEV1 and prevalence of pulmonary conditions in Japanese-American men. Am Rev Respir Dis (1988) 0.83